These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2885775

  • 1. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
    Murrin LC, Roth RH.
    Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
    [Abstract] [Full Text] [Related]

  • 2. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jun; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 3. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 4. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 5. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 29; 295(1):15-20. PubMed ID: 12482
    [Abstract] [Full Text] [Related]

  • 7. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P, Mereu G, Olianas MC, Bunse B, Rossetti Z, Gessa GL.
    Brain Res; 1985 Aug 05; 340(1):1-7. PubMed ID: 2862956
    [Abstract] [Full Text] [Related]

  • 8. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb 05; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 9. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra.
    Cumming P, Kamo H, McGeer EG, McGeer PL.
    Neuropharmacology; 1987 Dec 05; 26(12):1795-7. PubMed ID: 2893988
    [Abstract] [Full Text] [Related]

  • 10. Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis.
    Levine RA, Miller LP, Lovenberg W.
    Science; 1981 Nov 20; 214(4523):919-21. PubMed ID: 6117945
    [Abstract] [Full Text] [Related]

  • 11. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G, Onali PL, Tissari AH, Porceddu ML, Morelli M, Gessa GL.
    Life Sci; 1978 Aug 21; 23(7):691-6. PubMed ID: 29204
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A, Melis MR, Fadda F, Gessa GL.
    Brain Res; 1982 Feb 18; 234(1):177-81. PubMed ID: 6800566
    [Abstract] [Full Text] [Related]

  • 13. D1 receptor activation enhances sciatic nerve stimulation-induced inhibition of nigrostriatal dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1989 Feb 18; 3(4):339-45. PubMed ID: 2525823
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
    Cheronis JC, Erinoff L, Heller A, Hoffmann PC.
    Brain Res; 1979 Jun 29; 169(3):545-60. PubMed ID: 36209
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.
    Weiser SD, Patrick SL, Mascarella SW, Downing-Park J, Bai X, Carroll FI, Walker JM, Patrick RL.
    Eur J Pharmacol; 1995 Feb 24; 275(1):1-7. PubMed ID: 7774655
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec 24; 296(1):5-14. PubMed ID: 13315
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems.
    Tejedor-Real P, Faucon Biguet N, Dumas S, Mallet J.
    J Neurosci Res; 2003 Apr 01; 72(1):105-15. PubMed ID: 12645084
    [Abstract] [Full Text] [Related]

  • 18. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar 01; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 19. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
    Weiss-Wunder LT, Chesselet MF.
    Neuroscience; 1992 Jul 01; 49(2):297-305. PubMed ID: 1359452
    [Abstract] [Full Text] [Related]

  • 20. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT, McMillen BA, Sallis R, Blair D.
    J Pharmacol Exp Ther; 1986 Oct 01; 239(1):124-31. PubMed ID: 2876091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.